Altshuler Shaham LTD Aurinia Pharmaceuticals Inc. Transaction History

Altshuler Shaham LTD

  • $1.57 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$10.93 - $23.55 $6.11 Million - $13.2 Million
-559,412 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$10.0 - $14.52 $5.23 Million - $7.6 Million
523,412 Added 1453.92%
559,412 $7.25 Million
Q1 2021

May 13, 2021
BUY
$12.3 - $18.73 $442,800 - $674,280
36,000 New
36,000 $467,000

Others Institutions Holding AUPH

# of Institutions
209
Shares Held
58.7M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email